![]() | |
Discipline | Neurology |
---|---|
Language | English |
Edited by | Maral Mouradian |
Publication details | |
History | 2004-present |
Publisher | Elsevier Inc. on behalf of the American Society for Experimental NeuroTherapeutics |
Frequency | Quarterly |
5.6 (2020) | |
Standard abbreviations | |
ISO 4 | Neurotherapeutics |
Indexing | |
ISSN | 1933-7213 (print) 1878-7479 (web) |
LCCN | 2006215616 |
OCLC no. | 82448136 |
Links | |
Neurotherapeutics is a quarterly peer-reviewed medical journal covering research on experimental treatments of neurological disorders. It was established in 2004 and is published by Elsevier Inc. on behalf of the American Society for Experimental NeuroTherapeutics. The editor-in-chief is Maral Mouradian (Robert Wood Johnson Medical School). The founding editor-in-chief was Alan I. Faden (University of Maryland School of Medicine).
The journal is abstracted and indexed in:
According to the Journal Citation Reports , the journal has a 2020 impact factor of 7.620. [1]